肌营养不良蛋白缺乏改变肌膜结构,导致肌肉营养不良,肌肉废用,最终死亡。除了四肢肌肉缺陷,Duchenne型肌营养不良患者有许多运输障碍。许多研究强调了肠道微生物群与骨骼肌之间的密切关系。这项研究的目的是i)表征直到1岁的肠道微生物群组成,在缺乏肌营养不良蛋白的mdx小鼠中;ii)分析与回肠中细菌衍生代谢物相关的肠结构功能和基因的表达,血,胫骨前肌和比目鱼肌研究器官间的相互作用。Mdx小鼠显示不同操作分类单元的总数及其丰度(α-多样性)显着降低。Mdx基因型预测β多样性差异的20%,对四个门进行了大的分类学修改:放线菌,变形杆菌,Tenericutes,去铁杆菌和包含的属。有趣的是,mdx基因型回肠的肠动力、紧密连接和Ffar2受体基因表达下调。同时,与肠道微生物群相关的炎症通过循环炎症标志物的上调(TNF,IL-6,MCP-1)和肌肉炎症Tlr4/Myd88途径(TLR4称为细菌代谢物受体)。最后,在MDX小鼠中,脂联素在血液中降低,其受体在肌肉中被调节。这项研究强调了特定的肠道微生物群组成,并指出mdx生理病理学中器官间的相互作用,肠道微生物群作为潜在的中枢代谢器官。
Dystrophin deficiency alters the sarcolemma structure, leading to muscle dystrophy, muscle disuse, and ultimately death. Beyond limb muscle deficits, patients with Duchenne muscular dystrophy have numerous transit disorders. Many studies have highlighted the strong relationship between gut microbiota and skeletal muscle. The aims of this
study were: i) to characterize the gut microbiota composition over time up to 1 year in dystrophin-deficient mdx mice, and ii) to analyze the intestine structure and function and expression of genes linked to bacterial-derived metabolites in ileum, blood, and skeletal muscles to
study interorgan interactions. Mdx mice displayed a significant reduction in the overall number of different operational taxonomic units and their abundance (α-diversity). Mdx genotype predicted 20% of β-diversity divergence, with a large taxonomic modification of Actinobacteria, Proteobacteria, Tenericutes, and Deferribacteres phyla and the included genera. Interestingly, mdx intestinal motility and gene expressions of tight junction and Ffar2 receptor were down-regulated in the ileum. Concomitantly, circulating inflammatory markers related to gut microbiota (tumor necrosis factor, IL-6, monocyte chemoattractant protein-1) and muscle inflammation Tlr4/Myd88 pathway (Toll-like receptor 4, which recognizes pathogen-associated molecular patterns) were up-regulated. Finally, in mdx mice, adiponectin was reduced in blood and its receptor modulated in muscles. This
study highlights a specific gut microbiota composition and highlights interorgan interactions in mdx physiopathology with gut microbiota as the potential central metabolic organ.